MedPath

To compare the pain relieving efficacy postoperatively of preoperative infiltration of only Ropivacaine vs Ropivacaine plus dexmedetomidine injected in peritonsillar pillars in patients undergoing tonsillectomy.

Phase 4
Conditions
Health Condition 1: R590- Localized enlarged lymph nodes
Registration Number
CTRI/2024/06/069232
Lead Sponsor
Amala Kale
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)ASA grade 1 and 2 fit patients

2)Ages between 5 and 18 years f either gender

3) Patients posted for elective tonsillectomy under GA

4) Availability of informed consent

Exclusion Criteria

1)Patients with bleeding and coagulation disorders, hepatic and renal diseases, airway problems, patients with cognitive and developmental problems, patients with neurological and physiological disorders.

2) Patients with known hypersensitivity to the used local anaesthetic.

3) Patients who refused to participate in this study.

4)Signs of acute pharyngeal infection

5)Peritonsillar abscess

6)Use of regular anaesthetic medication

7) Patients below 5 years and above 18 years of age

8)ASA grade 3 and above

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare postoperative analgesia after infiltration of Ropivacaine vs Ropivacaine plus Dexmedetomidine preoperatively in anterior and posterior tonsillar pillarsTimepoint: After infiltration of the drug,both groups will be compared for analgesic efficacy immediately postoperatively at 1 hr,2 hr,4 hr,8 hr,12 hr,24 hr.
Secondary Outcome Measures
NameTimeMethod
To compare the analgesic efficacy of preoperative pillar infiltration of Dexmedetomidine in addition to Ropivacaine in tonsillectomy patientsTimepoint: To compare the time for first rescue analgesia, analgesic requirement in 24 hours,side effects like sedation,PONV, time of start of oral intake
© Copyright 2025. All Rights Reserved by MedPath